Activation of LA-N-2 cell phospholipases by single alanine substitution analogs of amyloid beta peptide (25-35)

被引:11
|
作者
Singh, IN
Sato, K
Takashima, A
Kanfer, JN
机构
[1] UNIV MANITOBA,DEPT BIOCHEM & MOL BIOL,WINNIPEG,MB R3E 0W3,CANADA
[2] MITSUBISHI KASEI INST LIFE SCI,MACHIDA,TOKYO 194,JAPAN
关键词
Alzheimer's disease; amyloid beta peptide; phospholipase A2; phospholipase C; phospholipase D; analogue;
D O I
10.1016/S0014-5793(97)00154-3
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
A series of single alanine substituted analogs of amyloid beta peptide (25-35) were tested for their ability to activate the phospholipases of cultured LA-N-2 cells. Substitution of alanine for the amino acids 29-34 prevented the activation of phospholipases A2 and D. In addition substitution of alanine at 28 prevented phospholipase D but not phospholipase A2 activation. All the alanine substitutions, except for positions 33 and 35, blunted phospholipase C activations. There were no activations by scrambled amyloid beta peptide. (C) 1997 Federation of European Biochemical Societies.
引用
收藏
页码:65 / 67
页数:3
相关论文
共 50 条
  • [41] THE TROPHIC EFFECT OF BETA-AMYLOID 25-35 PEPTIDE IS NOT MEDIATED BY NK1 OR BOMBESIN RECEPTORS
    BURGEVIN, MC
    DANIEL, N
    DOBLE, A
    BLANCHARD, JC
    NEUROREPORT, 1992, 3 (12) : 1131 - 1134
  • [42] Icariin inhibits beta-amyloid peptide segment 25-35 induced expression of β-secretase in rat hippocampus
    Nie, Jing
    Luo, Yong
    Huang, Xie-Nan
    Gong, Qi-Hai
    Wu, Qin
    Shi, Jing-Shan
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2010, 626 (2-3) : 213 - 218
  • [43] Folding and membrane insertion of amyloid-beta (25-35) peptide and its mutants: Implications for aggregation and neurotoxicity
    Tsai, Hui-Hsu Gavin
    Lee, Jian-Bin
    Tseng, Sheng-Shiuan
    Pan, Xiao-An
    Shih, Yuan-Ci
    PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS, 2010, 78 (08) : 1909 - 1925
  • [44] Structural characterization of amyloid beta-peptide (25-35) in presence of nicotine and its synthetic analogues.
    Esposito, C.
    Armenante, M. R.
    Scrima, M.
    Campiglia, P.
    D'Ursi, A. M.
    JOURNAL OF PEPTIDE SCIENCE, 2006, 12 : 195 - 195
  • [45] Protective effects of melatonin on cortico-hippocampal neurotoxicity induced by amyloid beta-peptide 25-35
    Shen, YX
    Wei, W
    Xu, SY
    ACTA PHARMACOLOGICA SINICA, 2002, 23 (01) : 71 - 76
  • [46] Cytotoxicity of beta-amyloid peptide 25-35 on vascular smooth muscle cells and attenuation by vitamin E
    Gwebu, ET
    Williams, J
    Mathis, D
    Warden, JA
    Selassie, M
    Richardson, S
    Gwebu, NT
    IN VITRO CELLULAR & DEVELOPMENTAL BIOLOGY-ANIMAL, 1997, 33 (09) : 672 - 673
  • [47] Intracerebroventricular administration of beta-amyloid peptide (25-35) induces oxidative stress and neurodegeneration in rat brain
    Gulyaeva, NV
    Victorov, IV
    Stepanichev, MY
    Onufriev, MV
    Mitrokhina, OS
    Moiseeva, YV
    Lazareva, NA
    PROGRESS IN ALZHEIMER'S AND PARKINSON'S DISEASES, 1998, 49 : 89 - 98
  • [48] Protective effects of Lingguizhugan decoction on amyloid-beta peptide (25-35)-induced cell injury Anti-inflammatory effects
    Feifei Xi
    Feng Sang
    Chunxiang Zhou
    Yun Ling
    NeuralRegenerationResearch, 2012, 7 (36) : 2867 - 2873
  • [49] Protective effects of Lingguizhugan decoction on amyloid-beta peptide (25-35)-induced cell injury Anti-inflammatory effects
    Xi, Feifei
    Sang, Feng
    Zhou, Chunxiang
    Ling, Yun
    NEURAL REGENERATION RESEARCH, 2012, 7 (36) : 2867 - 2873
  • [50] Involvement of the kappa opioidergic system in beta-amyloid peptide (25-35)-induced delayed amnesia in mice
    Watanabe, M
    Hiramatsu, M
    Ukai, M
    Kojima, R
    JAPANESE JOURNAL OF PHARMACOLOGY, 2002, 88 : 94P - 94P